When pharmaceutical facilities can cost hundreds of millions of euros, getting the numbers right from the outset is critical. Boehringer Ingelheim explains how it is combining AI, historical project data and robust governance to improve early-stage cost estimation and reduce investment risk.
Shutterstock - azrin_aziri